Literature DB >> 24515675

Prazosin for military combat-related PTSD nightmares: a critical review.

Brian W Writer, Eric G Meyer, Jason E Schillerstrom.   

Abstract

Military combat is a common trauma experience associated with posttraumatic stress disorder (PTSD). Trauma-related nightmares are a hallmark symptom of PTSD. They can be resistant to label-pharmacological PTSD treatment, and they are associated with a variety of adverse health outcomes. The purpose of this article is to review and evaluate prazosin therapy for combat-related PTSD nightmares. Consistent with available literature for all-causes PTSD nightmares, prazosin is an effective off-label option for combat-related PTSD nightmares. Future trials may further instruct use in specific combat-exposure profiles.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515675     DOI: 10.1176/appi.neuropsych.13010006

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  11 in total

Review 1.  Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.

Authors:  Philippe Yves Rémy Simon; Pierre-François Rousseau
Journal:  Can J Psychiatry       Date:  2016-07-19       Impact factor: 4.356

Review 2.  Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013.

Authors:  Scott H Waltman; David Shearer; Bret A Moore
Journal:  Curr Psychiatry Rep       Date:  2018-10-11       Impact factor: 5.285

3.  Nightmares in United States Military Personnel With Sleep Disturbances.

Authors:  Jennifer L Creamer; Matthew S Brock; Panagiotis Matsangas; Vida Motamedi; Vincent Mysliwiec
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

4.  Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress.

Authors:  Paul J Fitzgerald; Thomas F Giustino; Jocelyn R Seemann; Stephen Maren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 5.  Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder.

Authors:  Christoff Geldenhuys; Leigh L van den Heuvel; Petrus Steyn; Soraya Seedat
Journal:  CNS Drugs       Date:  2022-06-10       Impact factor: 6.497

6.  Acute sleep interventions as an avenue for treatment of trauma-associated disorders.

Authors:  Kevin M Swift; Connie L Thomas; Thomas J Balkin; Emily G Lowery-Gionta; Liana M Matson
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

7.  Somatic syndromes, insomnia, anxiety, and stress among sleep disordered breathing patients.

Authors:  Tshering Amdo; Nadia Hasaneen; Morris S Gold; Avram R Gold
Journal:  Sleep Breath       Date:  2016-01-21       Impact factor: 2.816

8.  Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD.

Authors:  Miriam L Rubin; Laurel A Copeland; Aimee R Kroll-Desrosiers; Alice G Knittel
Journal:  Psychopharmacol Bull       Date:  2020-05-19

Review 9.  Noradrenergic Modulation of Fear Conditioning and Extinction.

Authors:  Thomas F Giustino; Stephen Maren
Journal:  Front Behav Neurosci       Date:  2018-03-13       Impact factor: 3.558

10.  Locus coeruleus toggles reciprocal prefrontal firing to reinstate fear.

Authors:  Thomas F Giustino; Paul J Fitzgerald; Reed L Ressler; Stephen Maren
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.